Cryoport price target lowered to $15 from $18 at Roth MKM

Roth MKM analyst Richard Baldry lowered the firm’s price target on Cryoport (CYRX) to $15 from $18 and keeps a Buy rating on the shares. The company’s Q3 soft revenues were not a plus, but with Q2 results in-line for revenues and better at the adjusted EBITDA loss line, the lowered revenue guidance is less problematic than a nearing turn to EBITDA positive, the analyst tells investors in a research note.